Neuroute
PrivateLast Round
Seed
Sep 28, 2023
Total Funding Raised
$1.07M
Company Overview
Neuroute operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Seed round in September 2023.
Neuroute is a healthtech company that provides an AI-powered platform for clinical trial design, patient recruitment, and site selection.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Medical AI, Patient Engagement, Healthcare Analytics, Low-Code/No-Code
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neuroute Comparables
Compare Neuroute with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aurora Analytica | 83% | |
| BEKhealth | 83% | |
| Sano Genetics | 81% |
For institutional investors. Book with your work email.
Neuroute Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 28, 2023 | ||||
| Accelerator | Sep 16, 2022 | ||||
| Grant | Mar 8, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Neuroute Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nina Capital | Accelerator |
| PharmStars | Accelerator |
| Innovate UK | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors increased 38% MoM.
- May 3, 2025
Monthly visitors grew 1329% MoM, from 98 to 1.4K.
For institutional investors. Book with your work email.
Neuroute Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Neuroute's valuation, stock price, and market status.
Is Neuroute a public or private company?
Neuroute is a private company.
What is the current stock price of Neuroute?
Neuroute is a private company, so its shares have no public market price. Caplight tracks Neuroute's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Neuroute worth (valuation)?
Valuation information for Neuroute is not publicly available.
Can I buy Neuroute stock?
Neuroute shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Neuroute's last funding round?
Neuroute's most recent funding round was Seed on September 28, 2023.
Who are the main investors in Neuroute?
Key investors in Neuroute include Nina Capital, PharmStars, Innovate UK.
Will Neuroute IPO soon?
No public IPO plans have been announced for Neuroute.
How can I track Neuroute secondary market activity?
Caplight tracks bids, offers, and trades in Neuroute's shares on secondary markets.